SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001479290-19-000046
Filing Date
2019-05-08
Accepted
2019-05-08 16:08:42
Documents
3
Period of Report
2019-05-08
Items
Item 2.02: Results of Operations and Financial Condition

Document Format Files

Seq Description Document Type Size
1 8-K rvncq119er8-k.htm 8-K 36971
2 EXHIBIT 99.1 rvncq119exhibit991.htm EX-99.1 126798
3 RVNCLOGO rvnclogo.jpg GRAPHIC 20324
  Complete submission text file 0001479290-19-000046.txt   192927
Mailing Address 7555 GATEWAY BLVD. NEWARK CA 94560
Business Address 7555 GATEWAY BLVD. NEWARK CA 94560 510-742-3400
Revance Therapeutics, Inc. (Filer) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36297 | Film No.: 19806676
SIC: 2834 Pharmaceutical Preparations